Nurix Therapeutics Inc. (NRIX)
10.47
-1.41 (-11.87%)
At close: Apr 01, 2025, 3:59 PM
10.30
-1.62%
Pre-market: Apr 02, 2025, 08:05 AM EDT
Nurix Therapeutics Analyst Ratings
Total Analysts
17
Consensus Rating
Buy
Price Target
35
Upside
234.29
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Leerink Partners | Hold | Initiates | 16 | 52.82% | Mar 17, 2025 | |
| Morgan Stanley | Hold | Maintains | 16 17 | 62.37% | Feb 3, 2025 | |
| RBC Capital | Buy | Maintains | 26 27 | 157.88% | Jan 29, 2025 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.